Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
May 23, 2021

Europe’s medical devices industry saw a drop of 0% in deal activity during April 2021

Europe’s medical devices industry saw a flat growth in deal activity during April 2021, when compared with the last 12-month average, led by $5bn acquisition of CA Healthcare Acquisition and LumiraDx, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

 

A total of 34 medical devices industry deals worth $6.3bn were announced for the region in April 2021, against the 12-month average of 34 deals.

Of all the deal types, venture financing saw most activity in April 2021 with 18 transactions, representing a 52.9% share for the region.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

In second place was M&A with 13 deals, followed by private equity deals with three transactions, respectively capturing a 38.2% and 8.8% share of the overall deal activity for the month.

In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $6.08bn, followed by venture financing deals totalled $245.8m.

Europe medical devices industry deals in April 2021: Top deals

The top five medical devices deals accounted for 97.7% of the overall value during April 2021.

The combined value of the top five medical devices deals stood at $6.18bn, against the overall value of $6.3bn recorded for the month.

The top five medical devices industry deals of April 2021 tracked by GlobalData were:

1) The $5bn merger of CA Healthcare Acquisition and LumiraDx

2) The $795m acquisition deal with Mobidiag by Hologic

3) AddLife’s $216.53m acquisition of Vision Ophthalmology Group

4) The $115m venture financing of CeQur by Credit Suisse Entrepreneur Capital, Endeavour Vision, Federated Hermes Kaufmann Fund, GMS Capital, Kingdon Capital Management, SchroderBank AG, Tandem Diabetes Care, VI Partners and Ypsomed

5) Cambridge Innovation Capital, Earlybird Venture Capital GmbHKG, Jonathan Milner, Koch Disruptive Technologies and Mercia Asset Management’s venture financing of Sense Biodetection for $50m.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU